European Ombudsman grills Barroso over EMA data disclosure policy
This article was originally published in SRA
Executive Summary
In the latest development in the ongoing row over the European Medicines Agency's draft policy on proactive disclosure of clinical trial data, the European Ombudsman has written to European Commission president Jose Manuel Barroso demanding to see copies of all correspondence and contacts between the commission and the EMA regarding the policy1.